Serum prostate-specific antigen for prostate cancer early detection: total, free, age- stratified, or complexed?

This publication has 21 references indexed in Scilit:

• Implications of Stage-Specific Survival Rates in Assessing Recent Declines in Prostate Cancer Mortality Rates
  Epidemiology, 2000
• Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease
  JAMA, 1998
• Evaluation of ProstAsure Index in the Detection of Prostate Cancer: a Preliminary Report
  Urology, 1998
• Comparison of Percent Free Prostate Specific Antigen and Prostate Specific Antigen Density as Methods to Enhance Prostate Specific Antigen Specificity in Early Prostate Cancer Detection in Men With Normal Rectal Examination and Prostate Specific Antigen Between 4.1 and 10 ng./ml.
  Journal of Urology, 1997
• Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements
  JAMA, 1997
• Does free to total ratio of prostate-specific antigen alter decision-making on prostatic biopsy?
  Urology, 1996
• THE USE OF PROSTATE-SPECIFIC ANTIGEN AND FREE/TOTAL PROSTATE-SPECIFIC ANTIGEN IN THE DIAGNOSIS OF LOCALIZED PROSTATE CANCER
  Urologic Clinics of North America, 1996
• A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario
  Journal of Urology, 1996
• Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen
  Urology, 1996
• Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
  Published by American Medical Association (AMA) ,1995